Sign up to access historical data
Similar companies
Company | Est. Transaction Value | |
---|---|---|
Charles SchwabSCHW |
$3,500 | |
Morgan StanleyMS |
-$860,000 | |
BNY MellonBK |
-$24,000 | |
Goldman SachsGS |
-$1M | |
HSBCHSBC |
$130,000 |
Trades by US Politicians
Politician | Filing Date | Type | Size |
---|---|---|---|
Josh Gottheimer | Oct 17, 2024 | Sell | $1K - $15K |
Ro Khanna | Oct 14, 2024 | Buy | $1K - $15K |
Josh Gottheimer | May 10, 2024 | Buy | $1K - $15K |
Joshua Gottheimer Democrat | May 10, 2024 | Buy | $1K - $15K |
Rohit Khanna Democrat | May 6, 2024 | Sell | $1K - $15K |
Rohit Khanna Democrat | May 6, 2024 | Sell | $1K - $15K |
Rohit Khanna Democrat | May 6, 2024 | Sell | $1K - $15K |
Rohit Khanna Democrat | May 6, 2024 | Sell | $1K - $15K |
Rohit Khanna Democrat | May 2, 2024 | Sell | $1K - $15K |
Rohit Khanna Democrat | May 2, 2024 | Sell | $1K - $15K |
Rohit Khanna Democrat | May 1, 2024 | Sell | $1K - $15K |
Rohit Khanna Democrat | May 1, 2024 | Sell | $1K - $15K |
Rohit Khanna Democrat | May 1, 2024 | Sell | $1K - $15K |
Rohit Khanna Democrat | May 1, 2024 | Sell | $1K - $15K |
Rohit Khanna Democrat | Mar 21, 2024 | Sell | $1K - $15K |
Rohit Khanna Democrat | Mar 21, 2024 | Sell | $1K - $15K |
Rohit Khanna Democrat | Feb 15, 2024 | Sell | $1K - $15K |
Rohit Khanna Democrat | Feb 15, 2024 | Sell | $1K - $15K |
Joshua Gottheimer Democrat | Feb 8, 2024 | Buy | $1K - $15K |
Rohit Khanna Democrat | Feb 6, 2024 | Sell | $1K - $15K |
Rohit Khanna Democrat | Feb 6, 2024 | Sell | $1K - $15K |
Rohit Khanna Democrat | Feb 1, 2024 | Sell | $1K - $15K |
Rohit Khanna Democrat | Feb 1, 2024 | Sell | $1K - $15K |
Rohit Khanna Democrat | Jan 25, 2024 | Sell | $1K - $15K |
Rohit Khanna Democrat | Oct 20, 2023 | Buy | $1K - $15K |
Rohit Khanna Democrat | Sep 14, 2023 | Sell | $1K - $15K |
Rohit Khanna Democrat | Sep 14, 2023 | Sell | $1K - $15K |
Rohit Khanna Democrat | Sep 14, 2023 | Sell | $1K - $15K |
Lois Frankel Democrat | Sep 8, 2023 | Sell | $1K - $15K |
Rohit Khanna Democrat | May 10, 2023 | Buy | $1K - $15K |
Rohit Khanna Democrat | May 10, 2023 | Buy | $1K - $15K |
Rohit Khanna Democrat | Feb 15, 2023 | Buy | $1K - $15K |
Rohit Khanna Democrat | Feb 15, 2023 | Buy | $1K - $15K |
Rohit Khanna Democrat | Feb 8, 2023 | Sell | $1K - $15K |
Rohit Khanna Democrat | Feb 8, 2023 | Sell | $1K - $15K |
Shri Thanedar Democrat | Jan 23, 2023 | Sell | $15K - $50K |
Rohit Khanna Democrat | Jan 11, 2023 | Buy | $1K - $15K |
Rohit Khanna Democrat | Jan 11, 2023 | Buy | $1K - $15K |
Rohit Khanna Democrat | Dec 5, 2022 | Sell | $1K - $15K |
Who is the latest politician to buy or sell KKR & Co LP shares?
Josh Gottheimer sold KKR & Co LP shares most recently on October 17, 2024.
Which politician has bought the most KKR stock in the last two years?
Rohit Khanna has bought the most KKR stock in the last 2 years, with an estimated value of $56,000.
Which politician has sold the most KKR stock over the last two years?
Rohit Khanna has sold the most KKR stock in the last 2 years, with an estimated value of $200,000.
What is the total value of politicians trading KKR stock in the last 2 years?
The net value of trades by US politicians for KKR & Co LP in the last 2 years is negative, amounting to -$160,000. This suggests that US politicians do not believe in the success of the company for various reasons.
How do insider transactions over the last 2 years reflect on KKR & Co LP's market confidence?
Over the last 2 years, insider transactions for KKR & Co LP have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering politicians might have insights or reasons not immediately apparent to the public.
Why should individual investors pay attention to the stock transactions of US politicians?
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.